Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ladarixin Sodium, an Chemokine CXCR antagonist, is used potentially for the treatment of type I diabetes.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | 5 days | $ 177.00 | |
5 mg | 5 days | $ 297.00 | |
25 mg | 8-10 weeks | $ 916.00 | |
50 mg | 8-10 weeks | $ 1,190.00 | |
100 mg | 8-10 weeks | $ 1,890.00 | |
1 mL * 10 mM (in DMSO) | 5 days | $ 296.00 |
Description | Ladarixin Sodium, an Chemokine CXCR antagonist, is used potentially for the treatment of type I diabetes. |
Synonyms | DF 2156A, DF-2156, DF2156A, DF2156, DF 2156, DF-2156A |
Molecular Weight | 398.32 |
Formula | C11H12F3NNaO6S2 |
CAS No. | 865625-56-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Ladarixin Sodium 865625-56-5 DF 2156A DF-2156 DF2156A DF2156 DF 2156 DF-2156A inhibitor inhibit